- Oral presentation
- Open Access
Effectiveness of the SpineCor treatment for large scoliotic curves compared to moderate and small curves
© Coillard et al; licensee BioMed Central Ltd. 2012
- Published: 27 January 2012
- Tree Group
- Cohort Study
- Positive Outcome
- Retrospective Cohort
- Retrospective Cohort Study
657 consecutive scoliotic patients that accepted the treatment and had a definite outcome were included in this study. We divided the patients in tree groups depending on the initial Cobb angle: 15-29° (n=378), 30-39° (n=207) and 40-50° (n=72).
Assessment of brace effectiveness included; 1) percentage of patients who have 5° or less curve progression and the percentage of patients who have 6° or more progression at skeletal maturity, 2) percentage of patients who have had surgery recommendation before skeletal maturity.
Success of the treatment (stabilisation or correction) was achieved in 80.8% of patients with small curves compared to 62.9% for moderate and 46% for large curves. Progression of curves was observed in 14% of small curves compared with 28.9% for moderate and 48.5% for large curves. Two years follow-up post treatment 24.2% (for small), 17% (moderate) and respectively 16% (large) of patients that finished the treatment still corrected their Cobb angle without wearing the brace.
The SpineCor brace is effective for the treatment of large adolescent idiopathic scoliosis comparing with moderate curves. Moreover, the positive outcome appears to be maintained in the long term.
- Coillard C, Circo AB, Rivard CH: SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner. Scoliosis. 2010, 5: 25-10.1186/1748-7161-5-25.PubMed CentralView ArticlePubMedGoogle Scholar
- Coillard C, Vachon V, Circo A, Beausejour M, Rivard CH: Effectiveness of the SpineCor brace based on the new standardized criteria proposed by the Scoliosis Research Society for Adolescent Idiopathic Scoliosis. J Pediatr Orthop. 2007, 27: 375-379. 10.1097/01.bpb.0000271330.64234.db.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.